Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model

Autor: Mineharu, Yohei, Muhammad, AKM Ghulam, Yagiz, Kader, Candolfi, Marianela, Kroeger, Kurt M., Xiong, Weidong, Puntel, Mariana, Liu, Chunyan, Levy, Eva, Lugo, Claudia, Kocharian, Adrina, Allison, James P., Curran, Michael A., Lowenstein, Pedro R., Castro, Maria G.

Publikováno v: In Neurotherapeutics October 2012 9(4):827-843

Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen

Autor: King, Gwendalyn D, Muhammad, AKM Ghulam, Larocque, Daniel, Kelson, Kyle R, Xiong, Weidong, Liu, Chunyan, Sanderson, Nicholas SR, Kroeger, Kurt M, Castro, Maria G, Lowenstein, Pedro R

Publikováno v: In Molecular Therapy October 2011 19(10):1793-1801

Modulating amyloid‐beta proteostasis in the brain of 5xFAD mice by selective expression of angiotensin converting enzyme in microglia.

Autor: Gomez, Andrew, Wu, Shaogen, Byun, Hyae Ran, Muro, Alek, Muhammad, AKM Ghulam, Li, Lin, Tourtellotte, Warren G

Publikováno v: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2023 Supplement 13, Vol. 19, p1-2, 2p

Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation.

Autor: Candolfi M; Department of Neurosurgery, Department of Cell and Developmental Biology, University of Michigan School of Medicine, Ann Arbor, MI 48109-0650, USA., Kroeger KM, Xiong W, Liu C, Puntel M, Yagiz K, Muhammad AG, Mineharu Y, Foulad D, Wibowo M, Assi H, Baker GJ, Lowenstein PR, Castro MG

Publikováno v: Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2011 Oct; Vol. 11 (8), pp. 729-38.